When a hypomorphic mutation of LGR4 was observed in chronic myelogenous leukaemia (CML) stem cells, it induced inadequate disease-initiating capacity of CML cells in mice (Naka et al., 2020). The gene discussed is LGR4; the disease is chronic myelogenous leukemia, BCR-ABL1 positive.